Analyst Ratings for Teva Pharma (TEVA) [Sells]

TEVA Rating Summary

TEVA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TEVA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $57.31 (+1.5%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/30/2013 Goldman Sachs
» Updated 10/30/2013
Downgrade Sell
(Neutral)
40.00
(N/A)
39.90 56.45 41.48% Details
Like TEVA Ratings? Also take a look at MYL, OGXI, PFE, ACT

TEVA Ratings News